Physician profile
Jennifer Dochee
NPI 1093992836
$3,438.62
in general payments reported to CMS, 2019-2025
11 companies · $46.28 in 2025
The $46.28 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,696 · 2020: $1,659 · 2021: $17.88 · 2023: $18.90 · 2025: $46.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,034.31 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $94.11 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.44 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $51.58 | 2019-2025 | Rotapro |
| Amgen INC. | $49.13 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $45.14 | 2019-2021 | |
| Abbott Laboratories | $19.69 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $18.90 | 2023 | |
| Chiesi USA, INC. | $17.40 | 2020 | |
| W. L. Gore & Associates, INC. | $15.26 | 2019 | |
| Astellas Pharma US INC | $13.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Dochee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.